ABSTRACT
INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cancer in Malaysia. Despite advanced therapies, many cases of recurrence and resistance have been reported. Aberrant DNA methylation of HER3 has been implicated in carcinogenesis of CRC mainly through the regulation of gene expression. Hence, the objective of this study was to determine the status of HER3 DNA methylation and its effects on gene expression in CRC. MATERIALS AND METHODS: Fifty-nine of archival formalin-fixed, paraffin-embedded CRC cases with the adjacent normal colon tissues were retrieved. Manual micro-dissection was performed prior to RNA and DNA extraction. HER3 gene expression and DNA methylation status was evaluated by qPCR and methylation-specific PCR (MSP) techniques respectively. RESULTS: Upregulation of HER3 mRNA was found in CRC tissue compared to its adjacent normal colon tissue (8.04-fold). Of 59 CRC samples, 8.5% were methylated and 91.5% were unmethylated (hypomethylation). In the adjacent normal colon tissues, methylated and unmethylated tissue were observed in 6.8%and 93.2% respectively. DNA methylation of HER3 showed a significant association with tumour differentiation and tumour location. CONCLUSION: This study showed upregulation and hypomethylation of the HER3 gene in CRC cases. Epigenetic alterations were also found in the adjacent normal colon tissues. Thus, upregulation and hypomethylation of HER3 may play a key role in carcinogenesis of CRC. Hypomethylation of CpG islands might be associated with early steps during carcinogenesis. The findings of this biomarker serve a powerful approach to improve the current diagnostic and therapeutic measures.